BACK TO TOP

Allergy Clinical Trials

Criterium has recently concluded major asthma, allergy and respiratory studies in the following therapeutic indications:

  • Perennial Allergic Rhinitis
  • Seasonal Allergic Rhinitis
  • Allergic Conjunctivitis
  • Asthma mild, moderate, and severe (pediatric and adult)

With Offices in the USA, Canada, South Africa, India, Russia, Israel and Europe, we are poised to take advantage of our access to large patient populations for trials developing new therapies for COPD, Bacterial Sinusitis and other asthma, allergy and respiratory therapeutic areas.

For NECs, generics, reformulations and new indication aprovals, our multi-lingual staff of experts uses state-of-the-art technologies to conduct clinical trials in a time-efficient manner and deliver them at reasonable cost.

For more information contact Ronny Schnel:
Phone: (+ 1) 310-377-7517

GET TO KNOW US!

DOWNLOAD OUR BROCHURE